These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28492714)

  • 1. MAST CELLS DISTINGUISH EOSINOPHILIC ESOPHAGITIS IN PEDIATRIC PATIENTS.
    Lomazi EA; Brandalise NA; Servidoni MFPC; Cardoso SR; Meirelles LR
    Arq Gastroenterol; 2017; 54(3):192-196. PubMed ID: 28492714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
    Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Gebhart JH; Chen X; Woosley JT; Shaheen NJ
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2015-22. PubMed ID: 24993367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease.
    Dellon ES; Chen X; Miller CR; Fritchie KJ; Rubinas TC; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2011 Feb; 106(2):264-71. PubMed ID: 20978486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.
    Dohil R; Newbury RO; Aceves S
    Dig Dis Sci; 2012 May; 57(5):1413-9. PubMed ID: 22134787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.
    Sridhara S; Ravi K; Smyrk TC; Kita H; Kephart GM; Weiler CR; Katzka DA
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):735-41. PubMed ID: 22289868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E-bearing intraepithelial mast cells.
    Mulder DJ; Mak N; Hurlbut DJ; Justinich CJ
    Histopathology; 2012 Nov; 61(5):810-22. PubMed ID: 22978418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of eotaxin-3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor-responsive oesophageal eosinophilia and gastro-oesophageal reflux disease.
    Moawad FJ; Wells JM; Johnson RL; Reinhardt BJ; Maydonovitch CL; Baker TP
    Aliment Pharmacol Ther; 2015 Jul; 42(2):231-8. PubMed ID: 26011446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of proton pump inhibitor on esophageal eosinophilia.
    Schroeder S; Capocelli KE; Masterson JC; Harris R; Protheroe C; Lee JJ; Furuta GT
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):166-72. PubMed ID: 23325438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis.
    Reed CC; Genta RM; Youngblood BA; Wechsler JB; Dellon ES
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2102-2111. PubMed ID: 32801015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.
    Bolton SM; Kagalwalla AF; Arva NC; Wang MY; Amsden K; Melin-Aldana H; Dellon ES; Bryce PJ; Wershil BK; Wechsler JB
    Am J Gastroenterol; 2020 Feb; 115(2):224-233. PubMed ID: 31913192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center].
    Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
    Korean J Gastroenterol; 2016 Apr; 67(4):178-82. PubMed ID: 27112243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients.
    Jung DH; Yun GW; Lee YJ; Jo Y; Park H
    Gut Liver; 2016 Jan; 10(1):37-41. PubMed ID: 25963082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Reflux in the Pathogenesis of Eosinophilic Esophagitis: Comprehensive Appraisal With Off- and On PPI Impedance-pH Monitoring.
    Frazzoni M; Penagini R; Frazzoni L; de Bortoli N; Mauro A; Tolone S; Bertani H; Marsico M; Marocchi M; Marchi S; Conigliaro R; Savarino E
    Am J Gastroenterol; 2019 Oct; 114(10):1606-1613. PubMed ID: 31449157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oesophageal intrasquamous IgG4 deposits: an adjunctive marker to distinguish eosinophilic oesophagitis from reflux oesophagitis.
    Zukerberg L; Mahadevan K; Selig M; Deshpande V
    Histopathology; 2016 Jun; 68(7):968-76. PubMed ID: 26466342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease.
    Kirsch R; Bokhary R; Marcon MA; Cutz E
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):20-6. PubMed ID: 17204948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic and histological characteristics in patients with eosinophilic esophagitis responsive and non-responsive to proton pump inhibitors.
    Vieira GG; Ribeiro LBM; Truppel SK; Rosário Filho NA; Vieira MC
    J Pediatr (Rio J); 2020; 96(5):638-643. PubMed ID: 31361987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis.
    Le-Carlson M; Seki S; Abarbanel D; Quiros A; Cox K; Nadeau KC
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):257-62. PubMed ID: 23059644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor.
    Sá CC; Kishi HS; Silva-Werneck AL; Moraes-Filho JP; Eisig JN; Barbuti RC; Hashimoto CL; Navarro-Rodriguez T
    Clinics (Sao Paulo); 2011; 66(4):557-61. PubMed ID: 21655746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.